A new review of preclinical studies suggests GLP-1 drugs like Ozempic may reduce key proteins linked to Alzheimer’s disease.
You Might Also Like
Why Great Leaders Aren’t Always Available and What They Do Instead
Always available? You might be the reason your team isn’t stepping up.
0 Min Read
‘The New Phone Book’s Here!’ Was Once a Famous Quote. Here’s What It Means Today
When I unexpectedly got a phone book in my mailbox, I had hope that the Yellow Pages would still matter…
0 Min Read
Apple’s First Unionized Store Is Shutting Down—What Happens Next Could Matter Nationwide
Workers have filed a federal labor charge, alleging discrimination and unfair practices tied to the closure.
0 Min Read
The $52 Million Mystery: Why Citi Hired a Banking Exec Facing ‘Explosive’ Allegations—and Stands Behind It
In 2024, JPMorgan Chase pushed Vis Raghavan out after allegations of misconduct. Three days later, Citigroup hired him as its…
0 Min Read